Insulin and pentastarch for severe sepsis.
Muller
Laurent
L
Jaber
Samir
S
Lefrant
Jean Yves
JY
D003131:Combined Modality Therapy; D016638:Critical Illness; D005440:Fluid Therapy; D006801:Humans; D006895:Hydroxyethyl Starch Derivatives / Q000008:administration & dosage / Q000009:adverse effects*; D007003:Hypoglycemia / Q000139:chemically induced*; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D007328:Insulin / Q000008:administration & dosage / Q000009:adverse effects*; D051437:Renal Insufficiency / Q000209:etiology; D018805:Sepsis / Q000628:therapy*; D017211:Treatment Failure
D006895:Hydroxyethyl Starch Derivatives; D007004:Hypoglycemic Agents; D007328:Insulin